Siemens Healthcare Asserts its Leading Worldwide Position in Medical Technology

Siemens HealthcareThe Siemens Healthcare Sector has maintained its leading position in the field of medical technology despite a tough business environment. "In past years, we've expanded our product portfolio and even more consistently aligned it to customer needs," said Hermann Requardt, CEO of the Healthcare Sector, at the Siemens Healthcare Capital Market Day in London. "We're the only company that has been able to integrate magnetic resonance imaging (MRI) and positron emission tomography (PET) in one high-end unit and so to provide physicians with a new level of quality in imaging diagnostics. While expanding our high-end product portfolio, we have also strengthened our offering in the medium-price market segment, which is growing quickly worldwide. The Magnetom Spectra* is the most recent example of that. With this newly developed MRI system, we offer high-quality 3-tesla imaging at a very attractive price-performance ratio and are again setting new competitive standards." Financially, the Sector was able to perform at a very high level in a challenging business environment. "Siemens Healthcare is a highly attractive, inherently stable business," said Michael Sen, CFO of the Healthcare Sector. "The measures defined in Agenda 2013 broaden the basis for capital-efficient growth - in spite of anticipated structural changes in end markets and economic conditions that continue to be difficult."

Against the backdrop of a slowdown of the global economy and increasing pressure to reduce costs in healthcare systems, Siemens Healthcare has been able to maintain and partially even improve its leading worldwide position in medical technology. For instance, Siemens' market share in large imaging systems has steadily increased in recent years and now amounts to 36 percent. Siemens has thus strengthened its global leadership in this segment.

The dual-track strategy is proving its merit in enhancing both product portfolio and market coverage. As far as the product portfolio is concerned, Siemens Healthcare is the only provider able to master both the market for pioneering technologies like integrated MRI/PET systems and the medium-price segment at the same time. The Magnetom Spectra is the most recent proof of that. Thanks to its economic efficiency, hospitals and other radiological institutes can offer their patients high-quality 3-tesla imaging. As far as market coverage is concerned, Siemens Healthcare has over the past three years been able to more than offset the decrease in volume in the U.S. with annual growth of 27 percent in China. This makes China Siemens Healthcare's second largest market for imaging equipment and most important growth market. To continue to profit from this positive development, the Sector will intensify direct and indirect sales activities in emerging countries. In fiscal 2012, Siemens Healthcare's workforce in China is planned to be increased by about 700 employees.

Siemens Healthcare introduced its Agenda 2013 in November 2011. This two-year initiative defines a number of measures in the areas of innovation, competitiveness, regional footprint, and workforce development and so broadens the Sector's basis for future capital-efficient growth. The first measures have already been successfully implemented. Targeted investment in key R&D areas is designed to enlarge the product offering for the entry-level segment. To return to margin levels of previous fiscal years, the Diagnostics Division is carrying out effective cost-saving measures while simultaneously focusing its R&D activities on growth-oriented innovations. Also, cross-Sector purchasing volume will be increased in emerging countries to secure margins. Here, Siemens Healthcare is aiming for a target of 20 percent – three years ago it was just over 17 percent. Furthermore, savings have been achieved by reducing Sales, General and Administrative costs (SG&A). Between 2008 and 2011, the SG&A costs' share of revenue decreased by a total of nearly three percentage points.

Related news articles:

About Siemens Healthcare
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2011 (to September 30), the Sector posted revenue of 12.5 billion euros and profit of around 1.3 billion euros.

Most Popular Now

AI can Help Improve Emergency Room Admis…

Generative artificial intelligence (AI), such as GPT-4, can help predict whether an emergency room patient needs to be admitted to the hospital even with only minimal training on a limited...

Philips ePatch and AI Analytics Platform…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced the successful nationwide rollout of its ambulatory cardiac monitoring service in Spain using its unique wearable ePatch...

Comprehensive Bibliographic Dataset Adva…

A groundbreaking study published in Health Data Science, a Science Partner Journal, introduces a curated bibliographic dataset that aims to revolutionize the landscape of Health Artificial Intelligence (AI) research. Led...

New AI Algorithm may Improve Autoimmune …

A new advanced artificial intelligence (AI) algorithm may lead to better - and earlier - predictions and novel therapies for autoimmune diseases, which involve the immune system mistakenly attacking their...

AI Health Coach Lowers Blood Pressure an…

A new study in JMIR Cardio, published by JMIR Publications, shows that a fully digital, artificial intelligence (AI)-driven lifestyle coaching program can effectively reduce blood pressure (BP) in adults with...

Will Generative AI Change the Way Univer…

Since the launch of ChatGPT 3 in November 2022, we've been abuzz with talk of artificial intelligence: is it an unprecedented opportunity, or will it rob everyone of jobs and...

New Deep Learning Model is 'Game Ch…

Research led by the University of Plymouth has shown that a new deep learning AI model can identify what happens and when during embryonic development, from video. Published in the Journal...

Huge NHS Cloud Deals Mean Tough Question…

Opinion Article by Chris Scarisbrick, Deputy Managing Director, Sectra. The largest public cloud projects to ever take place within the NHS are beginning. Regional procurements for public cloud hosted diagnostic imaging...

AI Tech should Augment Physician Decisio…

The use of artificial intelligence (AI) in clinical health care has the potential to transform health care delivery but it should not replace physician decision-making, says the American College of...

A Three-Point Plan for Digital Delivery

Sam Shah has seen health tech policy up-close and worries that little progress has been made over the past five-years. However, he has a plan for any health and social...

Facial Thermal Imaging + AI Accurately P…

A combination of facial thermal imaging and artificial intelligence (AI) can accurately predict the presence of coronary artery disease, finds research published in the open access journal BMJ Health &...

New AI Algorithm Detects Rare Epileptic …

More than 3.4 million people in the US and 65 million people worldwide have epilepsy, a neurological disorder that affects the nervous system and causes seizures. One in 26 people...